{"id":3968,"date":"2021-11-03T13:25:41","date_gmt":"2021-11-03T13:25:41","guid":{"rendered":"http:\/\/www.enyopharma.com\/fr\/?p=3968"},"modified":"2021-11-03T13:30:27","modified_gmt":"2021-11-03T13:30:27","slug":"enyo-pharma-annonce-deux-presentations-de-donnees-sur-vonafexor-lors-de-la-conference-aasld-the-liver-meeting","status":"publish","type":"post","link":"https:\/\/www.enyopharma.com\/fr\/enyo-pharma-annonce-deux-presentations-de-donnees-sur-vonafexor-lors-de-la-conference-aasld-the-liver-meeting\/","title":{"rendered":"ENYO Pharma Annonce Deux Pr\u00e9sentations de Donn\u00e9es sur Vonafexor lors de la Conf\u00e9rence AASLD The Liver Meeting"},"content":{"rendered":"<p>Lyon, France. 3 Novembre 2021 &#8211; ENYO Pharma (ENYO), une soci\u00e9t\u00e9 priv\u00e9e de biotechnologie au stade clinique et d\u00e9veloppant des candidats-m\u00e9dicaments innovants, a annonc\u00e9 aujourd\u2019hui que deux abstracts sur Vonafexor avaient \u00e9t\u00e9 accept\u00e9s, l&#8217;un sous forme de pr\u00e9sentation orale et l&#8217;autre sous forme de poster, pour de la prochaine conf\u00e9rence 2021 The Liver Meeting\u00ae, organis\u00e9e par l&#8217;AASLD du 12 au 15 Novembre 2021.<\/p>\n <a href=\"http:\/\/www.enyopharma.com\/wp-content\/uploads\/2021\/10\/AASLD_2021_PR-_vFIN.pdf\" target=\"_blank\" rel=\"noopener\" target=\"_blank\" class=\"tano-file\"><span class=\"tano_download_icon\"><\/span><span class=\"tano_file_title\">T\u00e9l\u00e9charger le communiqu\u00e9 de presse (PDF)<\/span><\/a> \n","protected":false},"excerpt":{"rendered":"<p>Lyon, France. 3 Novembre 2021 &#8211; ENYO Pharma (ENYO), une soci\u00e9t\u00e9 priv\u00e9e de biotechnologie au stade clinique et d\u00e9veloppant des candidats-m\u00e9dicaments innovants, a annonc\u00e9 aujourd\u2019hui que deux abstracts sur Vonafexor avaient \u00e9t\u00e9 accept\u00e9s, l&#8217;un sous forme de pr\u00e9sentation orale et l&#8217;autre sous forme de poster, pour de la prochaine conf\u00e9rence 2021 The Liver Meeting\u00ae, organis\u00e9e par l&#8217;AASLD du 12 au 15 Novembre 2021.<\/p>\n<p><a class=\"read-more\" href=\"https:\/\/www.enyopharma.com\/fr\/enyo-pharma-annonce-deux-presentations-de-donnees-sur-vonafexor-lors-de-la-conference-aasld-the-liver-meeting\/\">Lire la suite&nbsp;&raquo;<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[17],"tags":[],"class_list":["post-3968","post","type-post","status-publish","format-standard","hentry","category-press-releases-fr"],"acf":[],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"","rttpg_featured_image_url":null,"rttpg_author":{"display_name":"editorENYOPharma","author_link":"https:\/\/www.enyopharma.com\/fr\/author\/editorenyopharma\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/www.enyopharma.com\/fr\/category\/press-releases-fr\/\" rel=\"category tag\">Press releases<\/a>","rttpg_excerpt":"Lyon, France. 3 Novembre 2021 &#8211; ENYO Pharma (ENYO), une soci\u00e9t\u00e9 priv\u00e9e de biotechnologie au stade clinique et d\u00e9veloppant des candidats-m\u00e9dicaments innovants, a annonc\u00e9 aujourd\u2019hui que deux abstracts sur Vonafexor avaient \u00e9t\u00e9 accept\u00e9s, l&#8217;un sous forme de pr\u00e9sentation orale et l&#8217;autre sous forme de poster, pour de la prochaine conf\u00e9rence 2021 The Liver Meeting\u00ae, organis\u00e9e&hellip;","_links":{"self":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts\/3968","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/comments?post=3968"}],"version-history":[{"count":4,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts\/3968\/revisions"}],"predecessor-version":[{"id":3978,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts\/3968\/revisions\/3978"}],"wp:attachment":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/media?parent=3968"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/categories?post=3968"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/tags?post=3968"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}